Yoshihiro Kawaoka discusses the key issues on benefits that need to be addressed in the assessments the NIH will undertake, while David Relman discusses the key issues on risks.
Негізгі бет Session 3: What is the debate on the potential risks and benefits of GOF research?
Пікірлер: 9